Us Bancorp \De\ Organogenesis Holdings Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.89 - $2.93 $137 - $213	73 Added 270.37%	100 $0
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.43 $942 - $1,303	-380 Reduced 93.37%	27 $0
Q3 2022 Oct 27, 2022	BUY	$3.14 - $6.43 $1,277 - $2,617	407 New	407 $1,000
Q2 2022 Aug 01, 2022	SELL	$4.74 - $8.15 $2,635 - $4,531	-556 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$6.47 - $9.57 $3,597 - $5,320	556 New	556 $4,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $462M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.